Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02995915 · ClinicalTrials.gov registry record · Phase 4
Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 45
- Enrollment target
NCT02995915 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 45 participants.
The verdict
NCT02995915, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 45 participants
- Enrollment target
Study Summary
Alcohol misuse and smoking constitute two of the three leading preventable causes of death in the United States. The purpose of this research study is to develop an intervention designed to help people stop drinking alcohol and stop smoking at the same time.
Interventions
- DRUG Bupropion
- BEHAVIORAL Cognitive Behavioral Treatment
- OTHER Nicotine Replacement Therapy
- BEHAVIORAL Mobile Contingency Management
- BEHAVIORAL Mobile Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-11 |
| Est. Completion | 2020-03-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02995915
The ClinicalTrials.gov registry entry for NCT02995915 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Bupropion is the first listed.
NCT02995915 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02995915 about?
NCT02995915 is a clinical study titled "Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking". Alcohol misuse and smoking constitute two of the three leading preventable causes of death in the United States. The purpose of this research study is to develop an intervention designed to help people stop drinking alcohol and stop smoking at the same time.
What is the current status of trial NCT02995915?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 45 participants. The study started on 2016-11. Estimated completion is 2020-03-02.
What interventions are being tested in trial NCT02995915?
The interventions under investigation include: Bupropion (DRUG), Cognitive Behavioral Treatment (BEHAVIORAL), Nicotine Replacement Therapy (OTHER), Mobile Contingency Management (BEHAVIORAL), Mobile Monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT02995915?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.